Literature DB >> 16836700

Nasal symptoms, airway obstruction and disease severity in chronic obstructive pulmonary disease.

John R Hurst1, Romana Kuchai, Philip Michael, Wayomi R Perera, Tom M A Wilkinson, Jadwiga A Wedzicha.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by inflammation of the lung in association with airflow obstruction. There is increasing evidence of upper airway involvement in COPD and we have reported that this nasal inflammation is proportional to that in the lung. Given recognized relationships between lower airway inflammation and spirometric indices such as the Forced Expiratory Volume in one second (FEV(1)), we hypothesized that there may be a relationship between nasal obstruction and FEV(1) in COPD. We also sought to investigate relationships between nasal symptoms and nasal patency in COPD.
METHODS: We assessed the nasal and pulmonary airways, using acoustic rhinometry and spirometry respectively, in 51 patients with COPD.
RESULTS: The presence of chronic nasal symptoms in COPD was associated with reduced nasal patency (6.04 cm(2) symptoms vs. 9.55 cm(2) no symptoms, at the second minimum cross-sectional area, P = 0.049). Nasal patency in COPD was inversely proportional to pulmonary airflow obstruction, and therefore to COPD disease severity (e.g. FEV(1)% predicted vs. second minimum cross-sectional area, r = 0.36, P = 0.009).
CONCLUSIONS: The degree of nasal airway obstruction in COPD reflects the impairment to pulmonary airflow, and is greater in the presence of chronic nasal symptoms. This study provides further evidence of pan-airway involvement in COPD.

Entities:  

Mesh:

Year:  2006        PMID: 16836700     DOI: 10.1111/j.1475-097X.2006.00683.x

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  5 in total

1.  Rhinosinusitis in COPD: symptoms, mucosal changes, nasal lavage cells and eicosanoids.

Authors:  Violetta M Piotrowska; Wojciech J Piotrowski; Zofia Kurmanowska; Jerzy Marczak; Paweł Górski; Adam Antczak
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-06-03

2.  Protocol for a human in vivo model of acute cigarette smoke inhalation challenge in smokers with COPD: monitoring the nasal and systemic immune response using a network biology approach.

Authors:  Clare L Ross; Neil Galloway-Phillipps; Paul C Armstrong; Jane A Mitchell; Timothy D Warner; Christopher Brearley; Mari Ito; Tanushree Tunstall; Sarah Elkin; Onn Min Kon; Trevor T Hansel; Mark J Paul-Clark
Journal:  BMJ Open       Date:  2015-01-28       Impact factor: 2.692

3.  Clinical impact of nasal budesonide treatment on COPD patients with coexistent rhinitis.

Authors:  Cecilia Calabrese; Adriano Costigliola; Marianna Maffei; Vittorio Simeon; Francesco Perna; Eugenio Tremante; Elena Merola; Carlo Antonio Leone; Andrea Bianco
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-06-27

4.  Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease.

Authors:  Marte Rystad Øie; Anne-Sofie Helvik; Malcolm Sue-Chu; Sverre Karmhus Steinsvåg; Wenche Moe Thorstensen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-09-07

5.  Upper airway symptoms associate with the eosinophilic phenotype of COPD.

Authors:  Nicolai Obling; Vibeke Backer; John R Hurst; Uffe Bodtger
Journal:  ERJ Open Res       Date:  2021-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.